share_log

B of A Securities Initiates Coverage On Inovio Pharmaceuticals with Neutral Rating, Announces Price Target of $13

B of A Securities Initiates Coverage On Inovio Pharmaceuticals with Neutral Rating, Announces Price Target of $13

B of A Securities以中性評級啟動對Inovio製藥的覆蓋，宣佈目標價為13美元
Benzinga Real-time News ·  2021/03/23 19:25

B of A Securities initiates coverage on Inovio Pharmaceuticals (NASDAQ:INO) with a Neutral rating and announces Price Target of $13.

美國銀行證券啟動對Inovio製藥的覆蓋(納斯達克：伊諾)評級為中性，並宣佈目標價為13美元。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論